Odyssey Therapeutics, Inc.

Direct answer

Odyssey Therapeutics, Inc. is publicly traded on NASDAQ under the ticker ODTX.

Odyssey Therapeutics, Inc., a clinical-stage biopharmaceutical company, develops medicines for autoimmune and inflammatory diseases. The company pipeline includes OD-001, an oral small molecule inhibitor of receptor-interacting protein kinase 2, which is in phase 2a trial for the treatment of ulcerative colitis; OD-002, an oral small molecule SLC15A4 inhibitor designed to block TLR7/8/9-mediated pathogenic...

Can you invest in Odyssey Therapeutics, Inc.?

Yes. Odyssey Therapeutics, Inc. trades publicly on NASDAQ as ODTX.

View deeper analysis

View detailed research on MarketSnap, including financials, valuation tools, and analyst context.

Open research for Odyssey Therapeutics, Inc.

Detailed equity research is provided by MarketSnap.